Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
Head and neck cancer is the fifth most common cancer worldwide. It is often amenable to curative intent therapy when localized to the head and neck region, but it carries a poor prognosis when it is recurrent or metastatic. Therefore, initial treatment decisions are critical to improve patient survival. However, multimodality therapy used with curative intent is toxic. The balance between offering intensive versus tolerable and function-preserving therapy has been thrown into sharp relief with the recently described epidemic of human papillomavirus-associated head and neck squamous cell carcinomas characterized by improved clinical outcomes compared with smoking-associated head and neck tumors. Model systems and clinical trials have been slow to address the clinical questions that face the field to date. With this as a background, a host of translational studies have recently reported the somatic alterations in head and neck cancer and have highlighted the distinct genetic and biologic differences between viral and tobacco-associated tumors. This review seeks to summarize the main findings of studies, including The Cancer Genome Atlas, for the clinician scientist, with a goal of leveraging this new knowledge toward the betterment of patients with head and neck cancer.
D. Neil Hayes, The University of North Carolina, Chapel Hill, NC; Carter Van Waes, National Institute on Deafness and Other Communication Disorders, Bethesda, MD; and Tanguy Y. Seiwert, The University of Chicago, Chicago, IL. hayes@med.unc.edu.
D Neil
DN
Hayes
D. Neil Hayes, The University of North Carolina, Chapel Hill, NC; Carter Van Waes, National Institute on Deafness and Other Communication Disorders, Bethesda, MD; and Tanguy Y. Seiwert, The University of Chicago, Chicago, IL.
Carter
C
Van Waes
D. Neil Hayes, The University of North Carolina, Chapel Hill, NC; Carter Van Waes, National Institute on Deafness and Other Communication Disorders, Bethesda, MD; and Tanguy Y. Seiwert, The University of Chicago, Chicago, IL.
Tanguy Y
TY
Seiwert
D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000821:virology; D018450:Disease Progression; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000821:virology; D006801:Humans; D030361:Papillomavirus Infections / Q000150:complications* / Q000453:epidemiology / Q000235:genetics*; D011379:Prognosis; D012907:Smoking / Q000009:adverse effects*